FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy

The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…

FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B

The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…

Yeztugo by Gilead Gets FDA OK, Promises Easier HIV Prevention

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)…